Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Effective COMMISSION IMPLEMENTING REGULATION (EU) 2018/155 of 31 January 2018 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (Text with EEA relevance)

Vyhláška č. 155/2018

Text language

Important dates

Declared: 31. januára 2018
Approved: 31. januára 2018
Effective from: 4. februára 2018

Documents and links

COMMISSION IMPLEMENTING REGULATION (EU) 2018/155

of 31 January 2018

amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 19, thereof,

Whereas:

(1)

Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 1 January 2022 and 31 December 2024 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation.

(2)

In view of the length of the evaluation process for active substances and the recent notification by the United Kingdom pursuant to Article 50 of the Treaty on European Union (3), it is necessary to re-allocate the evaluation of the active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 for which the United Kingdom is the rapporteur Member State or the co-rapporteur Member State, and for which no supplementary dossier has yet been submitted. The active substances concerned are aluminium ammonium sulphate, azoxystrobin, bupirimate, carbetamide, chlormequat, ethylene, fenbuconazole, fluopicolide, fluquinconazole, flutriafol, garlic extract, metazachlor, myclobutanil, paclobutrazol, pepper, plant oils/citronella oil, propaquizafop, quizalofop-p-ethyl, quizalofop-p-tefuryl, tri-allate and urea.

(3)

That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.

(4)

This Regulation should enter into force as soon as possible given that the deadline for the submission of the supplementary dossier for some of the active substances concerned is on 28 February 2018.

(5)

Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.

(6)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 31 January 2018.

For the Commission

The President

Jean-Claude JUNCKER

Prílohy

ANNEX

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

(1)

In Part B, the entries corresponding to active substances Aluminium ammonium sulphate, Azoxystrobin, Bupirimate, Carbetamide, Chlormequat, Ethylene, Fenbuconazole, Fluopicolide, Fluquinconazole, Flutriafol, Garlic extract, Metazachlor, Myclobutanil, Paclobutrazol, Pepper, Plant oils/Citronella oil, Propaquizafop, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Tri-allate and Urea are replaced by the following corresponding entries:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Aluminium ammonium sulphate

IE

PT’

‘Azoxystrobin

AT

NO’

‘Bupirimate

NL

PL’

‘Carbetamide

SE

BE’

‘Chlormequat

AT

IT’

‘Ethylene

NL

ES’

‘Fenbuconazole

SI

AT’

‘Fluopicolide

AT

ES’

‘Fluquinconazole

CZ

SK’

‘Flutriafol

SK

CZ’

‘Garlic extract

IE

DK’

‘Metazachlor

NL

PT’

‘Myclobutanil

AT

ES’

‘Paclobutrazol

AT

RO’

‘Pepper

BE

IE’

‘Plant oils/Citronella oil

FR

CZ’

‘Propaquizafop

AT

EE’

‘Quizalofop-P-ethyl

FI

SE’

‘Quizalofop-P-tefuryl

HR

AT’

‘Tri-allate

NL

CZ’

‘Urea

EL

FI’

(2)

The following Part C is added:

‘ PART C

ALLOCATION OF THE EVALUATION OF ACTIVE SUBSTANCES WHOSE APPROVAL EXPIRES AFTER 31 DECEMBER 2021 AND NOT LATER THAN 31 DECEMBER 2024

Active substance

Rapporteur Member State

Co-rapporteur Member State

1,4-Dimethylnaphthalene

AT

PL

Acequinocyl

DE

NL

Adoxophyes orana GV strain BV-0001

DE

FR

Ametoctradin

DE

NL

Aminopyralid

FI

DK

Amisulbrom

EL

FI

Ascorbic acid

NL

FR

Aureobasidium pullulans (strains DSM 14940 and DSM 14941)

AT

DE

Bacillus firmus I-1582

FR

DK

Bacillus pumilus QST 2808

IT

NL

Benalaxyl-M

PT

IT

Benzovindiflupyr

FR

AT

Bixafen

CZ

BE

Candida oleophila strain O

SI

DE

Chlorantraniliprole

IE

DE

Cyflumetofen

ES

AT

Disodium phosphonate

FR

EL

Emamectin

NL

SI

Esfenvalerate

AT

PT

Eugenol

ES

EL

Fenpyrazamine

LV

LT

Flubendiamide

EL

AT

Flumetralin

HU

EL

Fluopyram

AT

HR

Fluxapyroxad

FR

EL

Geraniol

ES

EL

Halosulfuron methyl

IT

PL

Helicoverpa armigera nucleopolyhedrovirus (HearNPV)

EE

FR

Ipconazole

BE

FR

Isopyrazam

NO

EL

lambda-Cyhalothrin

SE

FR

Maltodextrin

IE

FR

Mandipropamid

AT

PT

Metaflumizone

SE

EL

Metam (incl. -potassium and -sodium)

BE

ES

Metobromuron

FR

NO

Metsulfuron-methyl

DK

SE

Orange oil

FR

CZ

Paecilomyces fumosoroseus strain Fe9901

PL

NL

Penflufen

PL

IE

Penthiopyrad

SE

CZ

Phosphane

ES

DE

Potassium phosphonates (formerly potassium phosphite)

FR

EL

Prosulfuron

FR

SK

Pseudomonas sp. Strain DSMZ 13134

NL

BG

Pyridalyl

NL

BE

Pyriofenone

LV

EL

Pyroxsulam

DK

FI

S-Abscisic acid

NL

DK

Sedaxane

FR

AT

Sodium silver thiosulphate

NL

LV

Spinetoram

HR

ES

Spiromesifen

IT

AT

Spirotetramat

AT

NO

Spodoptera littoralis nucleopolyhedrovirus

EE

FR

Streptomyces lydicus WYEC 108

NL

DE

Tembotrione

AT

FR

Thiencarbazone

FR

EL

Thymol

ES

EL

Trichoderma asperellum (strain T34)

SE

IT

Trichoderma atroviride strain I-1237

IT

SK

Valifenalate (formerly Valiphenal)

HU

SI

Zucchini Yellow Mosaik Virus, weak strain

DK

AT’

Poznámky

(2)  Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances (OJ L 200, 27.7.2012, p. 5).